HBeAg seroconversion during treatment with peginterferon-alfa2a (PEG-IFN) is preceded by selection of hepatitis B virus basal core promoter and pre-core variants which are associated with decreased HBV replication
Keyword(s):
B Virus
◽
Keyword(s):
2010 ◽
Vol 46
(3)
◽
pp. 391-400
◽